MyMyelomaTeam

Great question! Think of smoldering multiple myeloma (SMM) and multiple myeloma (MM) as different points on the same journey. Here's a simple breakdown of the key differences:

Smoldering Multiple Myeloma (SMM)
- A precancerous condition — not yet active cancer
- Has elevated plasma cells and M protein levels, but causes Show Full Answer

Great question! Think of smoldering multiple myeloma (SMM) and multiple myeloma (MM) as different points on the same journey. Here's a simple breakdown of the key differences:

Smoldering Multiple Myeloma (SMM):
- A precancerous condition — not yet active cancer
- Has elevated plasma cells and M protein levels, but causes no symptoms
- Does not damage organs or bones
- Usually monitored rather than treated immediately

Multiple Myeloma (MM):
- An active blood cancer
- Causes noticeable symptoms like bone pain, fatigue, and nausea
- Can lead to organ damage, including kidney problems and bone lesions
- Requires active treatment such as chemotherapy, stem cell transplant, or other therapies The risk of SMM progressing to active myeloma is highest right after diagnosis and decreases over time:

- First 5 years: ~10% chance per year of developing active myeloma
- Years 5–10: drops to ~3% per year
- After 10 years: around 1% per year

Certain factors can increase the risk of progression, including high M protein levels, a high number of abnormal plasma cells in the bone marrow, and specific genetic changes.

Regular monitoring and check-ins with your care team are really important at every stage, so any changes can be caught early.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Smoldering Multiple Myeloma: Your Guide

Multiple Myeloma – An Overview